Demystifying Medicine

McMaster Undergraduate Course

HTH SCI 4DM3

Overview

The McMaster Demystifying Medicine Seminar Series is both an undergraduate course (HTS 4DM3) where students create well-researched videos and podcasts to further Knowledge Translation and Communication in the fields of science, technology, and medicine, as well as a collection where faculty and trainees present pathologies, patient diagnoses and therapies of major diseases and current research. This is designed to help increase the understanding of how advances in biology can be applied to diseases and discusses frequently emerging scientific, medical and ethical areas of interest.

 

Content

Most videos are directed towards individuals in university and medical settings, including students, faculty and clinicians, however many videos are perfectly suitable for high school students and even some for children (Look for the #KidZone next to the video title). Feel free to check out the latest videos below and also visit our YouTube Channel to stay up-to-date every time we upload a new video!

Antiviral pills: COVID-19 treatment at our fingertips

Nov 26, 2021, 16:00 PM by Maral Aminaei, Stefano Biasi, Lauren Birchenough, Wendy Tang
This video explores the roles of antiviral drugs in treating viral infections, and describes two forerunners in antiviral pill development.

With the global pandemic coming close to its two year anniversary, exciting progress is being made in the treatment and prevention of the deadly virus. Antiviral drugs have been used to treat several infections in the past, and can be administered in many different forms. Scientists are now developing antiviral pills to help in the treatment of patients infected with the SARS-CoV-2 virus. This video explores the roles of antiviral drugs in treating viral infections, and describes two forerunners in antiviral pill development. Merck & Co recently submitted an FDA application for their investigational drug Molnupiravir, and Pfizer’s investigational drug PF-07321332 is in the human subject testing phase. Both of these pills aim to treat patients diagnosed with COVID-19 and to decrease hospitalizations and deaths caused by the SARS-CoV-2 virus. While these pills are new and exciting, they should be used as an additional tool alongside vaccines. Watch this video to find out more about these antiviral pills and the treatment of COVID-19.

[Please complete our feedback form]









 

COVID-19 Videos

Antiviral pills: COVID-19 treatment at our fingertips

Nov 26, 2021, 16:00 PM by Maral Aminaei, Stefano Biasi, Lauren Birchenough, Wendy Tang
This video explores the roles of antiviral drugs in treating viral infections, and describes two forerunners in antiviral pill development.

With the global pandemic coming close to its two year anniversary, exciting progress is being made in the treatment and prevention of the deadly virus. Antiviral drugs have been used to treat several infections in the past, and can be administered in many different forms. Scientists are now developing antiviral pills to help in the treatment of patients infected with the SARS-CoV-2 virus. This video explores the roles of antiviral drugs in treating viral infections, and describes two forerunners in antiviral pill development. Merck & Co recently submitted an FDA application for their investigational drug Molnupiravir, and Pfizer’s investigational drug PF-07321332 is in the human subject testing phase. Both of these pills aim to treat patients diagnosed with COVID-19 and to decrease hospitalizations and deaths caused by the SARS-CoV-2 virus. While these pills are new and exciting, they should be used as an additional tool alongside vaccines. Watch this video to find out more about these antiviral pills and the treatment of COVID-19.

[Please complete our feedback form]









 



Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsaoda@mcmaster.ca.